To profile changes in gene expression in response to ischemic postconditioning, isolated rat hearts were subjected to 30 min of regional ischemia followed by 120 min of reperfusion with or without postconditioning. At the end of reperfusion, cardiac RNA was assayed by DNA microarrays (31,000 format), verified by quantitative real-time polymerase chain reaction (QRT-PCR). Postconditioning significantly up-regulated 50 genes and down-regulated 58 different genes, including pyruvate dehydrogenase, 60 kDa heat shock protein 1, lipoprotein lipase, gamma-sarcoglycan, and phospholipase C. Gene ontology analysis revealed that most of the altered genes belong to the cellular metabolic processes cluster. Many of the genes have not previously been suspected to be involved in the mechanism of postconditioning.
FerdinandyPSchulzRBaxterGF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev2007; 59: 418–58.
2.
OvizeMBaxterGFDi LisaFFerdinandyPGarcia-DoradoDHausenloyDJHeuschGVinten-JohansenJYellonDMSchulzR. Working Group of Cellular Biology of Heart of European Society of Cardiology. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res2010; 87: 406–23.
3.
NaHSKimYIYoonYWHanHCNahmSHHongSK. Ventricular premature beat-driven intermittent restoration of coronary blood flow reduces the incidence of reperfusion-induced ventricular fibrillation in a cat model of regional ischemia. Am Heart J1996; 132: 78–83.
4.
ZhaoZQCorveraJSHalkosMEKerendiFWangNPGuytonRAVinten-JohansenJ. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol2003; 285: H579–88.
5.
HausenloyDJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost2009; 101: 626–34.
6.
HeuschGBoenglerKSchulzR. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation2008; 118: 1915–9.
7.
OnodyAZvaraAHacklerLJrVighLFerdinandyPPuskasLG. Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett2003; 536: 35–40.
8.
CsonkaCSzilvassyZFulopFPaliTBlasigIETosakiASchulzRFerdinandyP. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation1999; 100: 2260–6.
9.
Csonka C, Kupai K, Kocsis GF, Novák G, Fekete V, Bencsik P, Csont T and Ferdinandy P. Measurement of myocardial infarct size in preclinical studies. J Pharmacol Toxicol Methods 2010;61:163–70.
10.
PuskasLGNagyZBGiriczZOnodyACsonkaCKitajkaKHacklerLJrZvaraAFerdinandyP. Cholesterol diet-induced hyperlipidemia influences gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett2004; 562: 99–104.
11.
DennisGJrShermanBTHosackDAYangJGaoWLaneHCLempickiRA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol2003; 4: P3–P3.
12.
ShermanBTHuang daWTanQGuoYBourSLiuDStephensRBaselerMWLaneHCLempickiRA. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics2007; 8: 426–426.
13.
MenesiDKitajkaKMolnarEKisZBellegerJNarceMKangJXPuskasLGDasUN. Gene and protein expression profiling of the fat-1 mouse brain. Prostaglandins Leukot Essent Fatty Acids2009; 80: 33–42.
14.
van der SpekPJKremerAMurryLWalkerMG. Are gene expression microarray analyses reliable? A review of studies of retinoic acid responsive genes. Genomics Proteomics Bioinformatics2003; 1: 9–14.
15.
LopaschukGDStanleyWC. Glucose metabolism in the ischemic heart. Circulation1997; 95: 313–5.
16.
CalvaniMRedaEArrigoni-MartelliE. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol2000; 95: 75–83.
17.
LopaschukGD. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?Coron Artery Dis2001; 12(Suppl 1): S8–11.
18.
LopaschukGDUssherJRFolmesCDJaswalJSStanleyWC. Myocardial fatty acid metabolism in health and disease. Physiol Rev2010; 90: 207–58.
19.
BoenglerKHeuschGSchulzR. Nuclear-encoded mitochondrial proteins and their role in cardioprotection. Biochim Biophys Acta2011; 1813: 1286–94.
20.
GorbeAVargaZVKupaiKBencsikPKocsisGFCsontTBoenglerKSchulzRFerdinandyP. Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. Am J Physiol Heart Circ Physiol2011; 300: H1907–13.
21.
SchulzRBoenglerKTotzeckALuoYGarcia-DoradoDHeuschG. Connexin 43 in ischemic pre- and postconditioning. Heart Fail Rev2007; 12: 261–6.
22.
KuoHCChengCFClarkRBLinJJLinJLHoshijimaMNguyen-TranVTGuYIkedaYChuPHRossJGilesWRChienKR. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell2001; 107: 801–13.
23.
KupaiKCsonkaCFeketeVOdendaalLvan RooyenJMarais deWCsontTFerdinandyP. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol2009; 297: H1729–35.
24.
PalmieriF. The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflugers Arch2004; 447: 689–709.
25.
de BoerRAVoorsAAMuntendamPvan GilstWHvan VeldhuisenDJ. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail2009; 11: 811–7.
26.
de BoerRAYuLvan VeldhuisenDJ. Galectin-3 in cardiac remodeling and heart failure. Curr Heart Fail Rep2010; 7: 1–8.
27.
SchroenBHeymansSSharmaUBlankesteijnWMPokharelSCleutjensJPPorterJGEveloCTDuistersRvan LeeuwenREJanssenBJDebetsJJSmitsJFDaemenMJCrijnsHJBornsteinPPintoYM. Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res2004; 95: 515–22.
28.
DicksteinKCohen-SolalAFilippatosGMcMurrayJJPonikowskiPPoole-WilsonPAStrombergAvan VeldhuisenDJAtarDHoesAWKerenAMebazaaANieminenMPrioriSGSwedbergK. ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail2008; 10: 933–89.
29.
YoshidaMSuzukiAYamamotoHNoguchiSMizunoYOzawaE. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem1994; 222: 1055–61.
30.
HackAAGrohMEMcNallyEM. Sarcoglycans in muscular dystrophy. Microsc Res Tech2000; 48: 167–80.
31.
OzawaEMizunoYHagiwaraYSasaokaTYoshidaM. Molecular and cell biology of the sarcoglycan complex. Muscle Nerve2005; 32: 563–76.
32.
BereczkiEGondaSCsontTKorposEZvaraAFerdinandyPSanthaM. Overexpression of biglycan in the heart of transgenic mice: an antibody microarray study. J Proteome Res2007; 6: 854–61.
33.
CsontTFerdinandyP. Letter by Csont and Ferdinandy regarding article, “Biglycan is required for adaptive remodeling after myocardial infarction”. Circulation2008; 118: e521–e521. author reply e522.
34.
CsontTGorbeABereczkiESzunyogAAyparETothMEVargaZVCsonkaCFulopFSanthaMFerdinandyP. Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: role of nitric oxide. J Mol Cell Cardiol2010; 48: 649–52.
35.
HausenloyDJErik BotkerHCondorelliGFerdinandyPGarcia-DoradoDHeuschGLecourSvan LaakeLWMadonnaRRuiz-MeanaMSchulzRSluijterJPYellonDMOvizeM. Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res2013; 98: 7–27.
